Evidence map›Paper›PMID 31481960›Full record

ArticleFrontiers in immunology2019

Human Intestinal Enteroids Model MHC-II in the Gut Epithelium.

Jonathan E Wosen, Alexandra Ilstad-Minnihan, Julia Y Co, Wei Jiang, Dhriti Mukhopadhyay, Nielsen Q Fernandez-Becker, Calvin J Kuo, Manuel R Amieva, Elizabeth D Mellins

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Regulation of NK-Cell Function by HLA Class II.Frontiers in cellular and infection microbiology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Jonathan E WosenProgram in Immunology, Department of Pediatrics, Stanford University, Stanford, CA, United States.
Alexandra Ilstad-MinnihanProgram in Immunology, Department of Pediatrics, Stanford University, Stanford, CA, United States.
Julia Y CoDivision of Infectious Diseases, Department of Pediatrics, Stanford University, Stanford, CA, United States.
Wei JiangProgram in Immunology, Department of Pediatrics, Stanford University, Stanford, CA, United States.
Dhriti MukhopadhyayProgram in Immunology, Department of Pediatrics, Stanford University, Stanford, CA, United States.
Nielsen Q Fernandez-BeckerDivision of Gastroenterology and Hepatology, Department of Medicine, Stanford University, Stanford, CA, United States.
Calvin J KuoDivision of Hematology, Department of Medicine, Stanford University, Stanford, CA, United States.
Manuel R AmievaDivision of Infectious Diseases, Department of Pediatrics, Stanford University, Stanford, CA, United States.
Elizabeth D MellinsProgram in Immunology, Department of Pediatrics, Stanford University, Stanford, CA, United States.
Stanford University · US

Funding

Stanford/UNC Biomimetic U19 Research CenterU19AI116484 · NIAID · STANFORD UNIVERSITY · PI AMIEVA, MANUEL R, KUO, CALVIN J · 2015 to 2025
$13.5M
UCSF Project 1U54CA224081 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CALVIN J KUO · 2017 to 2026
$12.9M
Regulation of actively proliferating and quiescent intestinal stem cellsU01DK085527 · NIDDK · STANFORD UNIVERSITY · PI KUO, CALVIN J · 2009 to 2023
$6.9M
Intestinal Stem Cell Consortium Coordinating CenterU01DK085532 · NIDDK · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI NILAND, JOYCE CAROL · 2009 to 2018
$6.5M
Limited Competition for the Continuation of the Intestinal Stem Cell Consortium Coordinating CenterU24DK085532 · NIDDK · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI NILAND, JOYCE CAROL · 2019 to 2023
$2.3M
NCI NIH HHS U54 CA224081NIAID NIH HHS U19 AI116484NIDDK NIH HHS U01 DK085527NIDDK NIH HHS U01 DK085532NIDDK NIH HHS U24 DK085532
6 · The paper itself

Abstract

The role of intestinal epithelial cells (IECs) in mucosal tolerance and immunity remains poorly understood. We present a method for inducing MHC class II (MHC-II) in human enteroids, "mini-guts" derived from small intestinal crypt stem cells, and show that the intracellular MHC-II peptide-pathway is intact and functional in IECs. Our approach enables human enteroids to be used for novel

Indexed as

Histocompatibility Antigens Class IIHumansIntestinal MucosaOrganoidsHistocompatibility Antigens Class IIantigen presentationenteroid cultureepithelial cellsMHC-IImucosal immunity

Identifiers

PMID31481960
PMCPMC6710476
OpenAlexW2965840822

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.